US Stock MarketDetailed Quotes

PHARMA-BIO SERVICES INC (PBSV)

Watchlist
  • 0.5000
  • 0.00000.00%
15min DelayClose Apr 13 14:53 ET
11.45MMarket Cap-166.67P/E (TTM)

PHARMA-BIO SERVICES INC (PBSV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Total revenue
-7.14%2.29M
-5.34%9M
-7.87%2.15M
-18.82%1.96M
1.66%2.42M
3.83%2.47M
-43.99%9.51M
-35.15%2.33M
-47.17%2.42M
-47.90%2.38M
Operating revenue
-7.14%2.29M
-5.34%9M
-7.87%2.15M
-18.82%1.96M
1.66%2.42M
3.83%2.47M
-43.99%9.51M
-35.15%2.33M
-47.17%2.42M
-47.90%2.38M
Cost of revenue
-7.67%1.57M
-12.90%6.09M
-12.82%1.4M
-22.10%1.39M
-9.14%1.6M
-7.66%1.7M
-41.28%6.99M
-39.79%1.61M
-41.11%1.78M
-45.31%1.76M
Gross profit
-5.95%722.37K
15.66%2.91M
3.08%748.94K
-9.62%574.26K
32.38%818.73K
43.41%768.11K
-50.34%2.52M
-21.86%726.57K
-59.01%635.38K
-54.07%618.48K
Operating expense
-5.04%816.91K
-6.73%3.55M
0.17%882.21K
-12.68%888.14K
-1.59%917.05K
-11.67%860.3K
-3.68%3.8M
-10.28%880.7K
-6.64%1.02M
-3.57%931.85K
Selling and administrative expenses
-5.04%816.91K
-6.73%3.55M
0.17%882.21K
-12.68%888.14K
-1.59%917.05K
-11.67%860.3K
-3.68%3.8M
-10.28%880.7K
-6.64%1.02M
-3.57%931.85K
Operating profit
-2.54%-94.54K
50.48%-637.66K
13.53%-133.27K
17.79%-313.88K
68.62%-98.32K
78.97%-92.19K
-215.23%-1.29M
-197.75%-154.13K
-182.91%-381.78K
-182.45%-313.38K
Net non-operating interest income expense
Other net income (expense)
28.66%131.03K
2.12%543.4K
-1.26%137.53K
14.47%104.85K
64.98%199.19K
-43.59%101.84K
-6.65%532.14K
3,444.05%139.28K
-27.87%91.59K
-37.32%120.74K
Other non- operating income (expenses)
28.66%131.03K
2.12%543.4K
-1.26%137.53K
14.47%104.85K
64.98%199.19K
-43.59%101.84K
-6.65%532.14K
3,444.05%139.28K
-27.87%91.59K
-37.32%120.74K
Income before tax
278.10%36.49K
87.52%-94.26K
128.65%4.25K
27.97%-209.03K
152.36%100.86K
103.74%9.65K
-144.77%-755.45K
68.96%-14.85K
-149.40%-290.19K
-133.64%-192.64K
Income tax
225.56%3.63K
-72.02%6.2K
114.07%4.36K
-125.15%-4.78K
-73.98%5.51K
-91.39%1.12K
-94.12%22.17K
-4,406.55%-30.96K
-68.95%19K
-87.40%21.18K
Net income
284.96%32.86K
87.08%-100.46K
-100.63%-102
33.94%-204.25K
144.60%95.35K
103.15%8.54K
-159.35%-777.62K
134.17%16.11K
-158.76%-309.19K
-152.84%-213.82K
Net income continuous Operations
284.96%32.86K
87.08%-100.46K
-100.63%-102
33.94%-204.25K
144.60%95.35K
103.15%8.54K
-159.35%-777.62K
134.17%16.11K
-158.76%-309.19K
-152.84%-213.82K
Minority interest income
Net income attributable to the parent company
284.96%32.86K
87.08%-100.46K
-100.63%-102
33.94%-204.25K
144.60%95.35K
103.15%8.54K
-159.35%-777.62K
134.17%16.11K
-158.76%-309.19K
-152.84%-213.82K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
284.96%32.86K
87.08%-100.46K
-100.63%-102
33.94%-204.25K
144.60%95.35K
103.15%8.54K
-159.35%-777.62K
134.17%16.11K
-158.76%-309.19K
-152.84%-213.82K
Basic earnings per share
0.001
88.24%-0.004
0
35.71%-0.009
144.44%0.004
0
-159.65%-0.034
150.00%0.001
-160.87%-0.014
-150.00%-0.009
Diluted earnings per share
0.001
88.24%-0.004
0
35.71%-0.009
144.44%0.004
0
-159.65%-0.034
150.00%0.001
-160.87%-0.014
-150.00%-0.009
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Total revenue -7.14%2.29M-5.34%9M-7.87%2.15M-18.82%1.96M1.66%2.42M3.83%2.47M-43.99%9.51M-35.15%2.33M-47.17%2.42M-47.90%2.38M
Operating revenue -7.14%2.29M-5.34%9M-7.87%2.15M-18.82%1.96M1.66%2.42M3.83%2.47M-43.99%9.51M-35.15%2.33M-47.17%2.42M-47.90%2.38M
Cost of revenue -7.67%1.57M-12.90%6.09M-12.82%1.4M-22.10%1.39M-9.14%1.6M-7.66%1.7M-41.28%6.99M-39.79%1.61M-41.11%1.78M-45.31%1.76M
Gross profit -5.95%722.37K15.66%2.91M3.08%748.94K-9.62%574.26K32.38%818.73K43.41%768.11K-50.34%2.52M-21.86%726.57K-59.01%635.38K-54.07%618.48K
Operating expense -5.04%816.91K-6.73%3.55M0.17%882.21K-12.68%888.14K-1.59%917.05K-11.67%860.3K-3.68%3.8M-10.28%880.7K-6.64%1.02M-3.57%931.85K
Selling and administrative expenses -5.04%816.91K-6.73%3.55M0.17%882.21K-12.68%888.14K-1.59%917.05K-11.67%860.3K-3.68%3.8M-10.28%880.7K-6.64%1.02M-3.57%931.85K
Operating profit -2.54%-94.54K50.48%-637.66K13.53%-133.27K17.79%-313.88K68.62%-98.32K78.97%-92.19K-215.23%-1.29M-197.75%-154.13K-182.91%-381.78K-182.45%-313.38K
Net non-operating interest income expense
Other net income (expense) 28.66%131.03K2.12%543.4K-1.26%137.53K14.47%104.85K64.98%199.19K-43.59%101.84K-6.65%532.14K3,444.05%139.28K-27.87%91.59K-37.32%120.74K
Other non- operating income (expenses) 28.66%131.03K2.12%543.4K-1.26%137.53K14.47%104.85K64.98%199.19K-43.59%101.84K-6.65%532.14K3,444.05%139.28K-27.87%91.59K-37.32%120.74K
Income before tax 278.10%36.49K87.52%-94.26K128.65%4.25K27.97%-209.03K152.36%100.86K103.74%9.65K-144.77%-755.45K68.96%-14.85K-149.40%-290.19K-133.64%-192.64K
Income tax 225.56%3.63K-72.02%6.2K114.07%4.36K-125.15%-4.78K-73.98%5.51K-91.39%1.12K-94.12%22.17K-4,406.55%-30.96K-68.95%19K-87.40%21.18K
Net income 284.96%32.86K87.08%-100.46K-100.63%-10233.94%-204.25K144.60%95.35K103.15%8.54K-159.35%-777.62K134.17%16.11K-158.76%-309.19K-152.84%-213.82K
Net income continuous Operations 284.96%32.86K87.08%-100.46K-100.63%-10233.94%-204.25K144.60%95.35K103.15%8.54K-159.35%-777.62K134.17%16.11K-158.76%-309.19K-152.84%-213.82K
Minority interest income
Net income attributable to the parent company 284.96%32.86K87.08%-100.46K-100.63%-10233.94%-204.25K144.60%95.35K103.15%8.54K-159.35%-777.62K134.17%16.11K-158.76%-309.19K-152.84%-213.82K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 284.96%32.86K87.08%-100.46K-100.63%-10233.94%-204.25K144.60%95.35K103.15%8.54K-159.35%-777.62K134.17%16.11K-158.76%-309.19K-152.84%-213.82K
Basic earnings per share 0.00188.24%-0.004035.71%-0.009144.44%0.0040-159.65%-0.034150.00%0.001-160.87%-0.014-150.00%-0.009
Diluted earnings per share 0.00188.24%-0.004035.71%-0.009144.44%0.0040-159.65%-0.034150.00%0.001-160.87%-0.014-150.00%-0.009
Dividend per share 0000000000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More